Hyperhomocysteinemia in chronic renal disease.

Suppr

超能文献

作者信息

Bostom A G, Culleton B F

机构信息

Memorial Hospital of Rhode Island, Pawtucket 02860, USA.

出版信息

J Am Soc Nephrol. 1999 Apr;10(4):891-900. doi: 10.1681/ASN.V104891.

DOI:10.1681/ASN.V104891

PMID:10203375

Abstract

摘要

相似文献

Hyperhomocysteinemia in chronic renal disease.

J Am Soc Nephrol. 1999 Apr;10(4):891-900. doi: 10.1681/ASN.V104891.

[Renal insufficiency is an important cardiovascular risk factor].肾功能不全是一个重要的心血管危险因素。

Nefrologia. 2002;22(4):306-9.

[Hyperhomocysteinemia as a risk factor for cardiovascular diseases in patients with chronic renal failure].

Pol Arch Med Wewn. 2000 Oct;104(4):695-701.

Hyperhomocysteinemia: a renal and cardiovascular risk factor?高同型半胱氨酸血症：一种肾脏和心血管危险因素？

Nat Rev Nephrol. 2010 Dec;6(12):695-6. doi: 10.1038/nrneph.2010.142.

Hyperhomocysteinemia in end stage renal disease: is treatment necessary?

Nephrol Nurs J. 2002 Apr;29(2):155-60; quiz 161-2.

Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.

Semin Nephrol. 2006 Jan;26(1):20-3. doi: 10.1016/j.semnephrol.2005.06.005.

Emerging cardiovascular risk factors in end-stage renal disease.终末期肾病中新出现的心血管危险因素。

J Nephrol. 2002 Mar-Apr;15(2):205-8.

Effect of hyperhomocysteinemia on endothelial activation and dysfunction in patients with end-stage renal disease.高同型半胱氨酸血症对终末期肾病患者内皮激活及功能障碍的影响。

Am J Cardiol. 2001 Nov 15;88(10):1203-5. doi: 10.1016/s0002-9149(01)02064-1.

Hyperhomocysteinemia and vascular disease: role and implications.高同型半胱氨酸血症与血管疾病：作用及影响

J Assoc Physicians India. 2002 May;50 Suppl:5-8.

Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.高同型半胱氨酸血症、血管病理学与内皮功能障碍。

Semin Thromb Hemost. 2000;26(3):281-9. doi: 10.1055/s-2000-8472.

引用本文的文献

Pathophysiological concepts and screening of cardiovascular disease in dialysis patients.透析患者心血管疾病的病理生理概念与筛查

Front Nephrol. 2023 Sep 29;3:1198560. doi: 10.3389/fneph.2023.1198560. eCollection 2023.

Homocysteine exchange across skeletal muscle in patients with chronic kidney disease.慢性肾脏病患者骨骼肌内的同型半胱氨酸交换。

Physiol Rep. 2023 Mar;11(6):e15573. doi: 10.14814/phy2.15573.

Hyperhomocysteinemia Increases Vascular Risk in Stroke Patients with Chronic Kidney Disease.高同型半胱氨酸血症增加慢性肾脏病脑卒中患者的血管风险。

J Atheroscler Thromb. 2023 Sep 1;30(9):1198-1209. doi: 10.5551/jat.63849. Epub 2022 Nov 26.

Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency.尿甲基丙二酸/肌酐比值在维生素B12缺乏症中的诊断效能

J Clin Med. 2020 Jul 22;9(8):2335. doi: 10.3390/jcm9082335.

Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses.同型半胱氨酸与 IgA 肾病：观察性和孟德尔随机化分析。

Chin Med J (Engl). 2020 Feb 5;133(3):277-284. doi: 10.1097/CM9.0000000000000613.

Possible Modulation of Vascular Function Measures in Rheumatoid Arthritis by Homocysteine.同型半胱氨酸对类风湿关节炎血管功能指标的潜在调节作用

Int J Rheumatol. 2018 Jul 2;2018:8498651. doi: 10.1155/2018/8498651. eCollection 2018.

Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury.高同型半胱氨酸血症加重顺铂诱导的急性肾损伤。

Int J Biol Sci. 2017 Feb 6;13(2):219-231. doi: 10.7150/ijbs.16725. eCollection 2017.

Association of E-selectin with hematological, hormonal levels and plasma proteins in children with end stage renal disease.终末期肾病患儿中E选择素与血液学指标、激素水平及血浆蛋白的相关性

Adv Biomed Res. 2016 Jul 29;5:118. doi: 10.4103/2277-9175.186992. eCollection 2016.

Interventions for lowering plasma homocysteine levels in dialysis patients.降低透析患者血浆同型半胱氨酸水平的干预措施。

Cochrane Database Syst Rev. 2016 May 31;2016(5):CD004683. doi: 10.1002/14651858.CD004683.pub4.

Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.定义近期开始血液透析患者的尿毒症动脉功能异常：体内与体外联合评估

PLoS One. 2014 Dec 29;9(12):e113462. doi: 10.1371/journal.pone.0113462. eCollection 2014.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验